Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)
Hong Kong · Delayed Price · Currency is HKD 31.18
+0.12 (0.39%)
At close: Mar 27, 2026
HKG:1501 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,065 | 851.95 | 752.84 | 585.88 | 464.68 | |
Revenue Growth (YoY) | 25.06% | 13.17% | 28.50% | 26.08% | 29.64% |
Cost of Revenue | 428.69 | 314.29 | 314.77 | 253.4 | 188.93 |
Gross Profit | 636.79 | 537.66 | 438.07 | 332.49 | 275.75 |
Selling, General & Admin | 266.05 | 200.23 | 166.82 | 120.68 | 79.07 |
Research & Development | 150.06 | 149.13 | 125.85 | 99.63 | 89.96 |
Other Operating Expenses | -50.56 | -23.1 | -17 | -18.1 | -38.49 |
Operating Expenses | 365.55 | 325.64 | 276.08 | 203.14 | 131.11 |
Operating Income | 271.24 | 212.02 | 161.99 | 129.34 | 144.64 |
Interest Expense | -12.54 | -2.43 | -3.19 | -0.82 | -0.63 |
Interest & Investment Income | - | 9.11 | 11.83 | 13.41 | 14.53 |
Earnings From Equity Investments | -0.59 | -0.4 | - | - | - |
Currency Exchange Gain (Loss) | - | 3.11 | 2.42 | 2.54 | -2.84 |
EBT Excluding Unusual Items | 258.11 | 221.41 | 173.05 | 144.47 | 155.69 |
Gain (Loss) on Sale of Investments | - | -8.03 | 2.08 | - | - |
Asset Writedown | 0.21 | - | - | - | - |
Pretax Income | 258.32 | 213.38 | 175.13 | 144.47 | 155.69 |
Income Tax Expense | 25.65 | 23.34 | 21.9 | 10.64 | 15.25 |
Earnings From Continuing Operations | 232.67 | 190.05 | 153.23 | 133.83 | 140.45 |
Minority Interest in Earnings | -13.89 | 1.87 | 3.23 | -2.12 | 2.52 |
Net Income | 218.79 | 191.91 | 156.46 | 131.71 | 142.96 |
Preferred Dividends & Other Adjustments | - | 11 | 4.58 | 1.57 | - |
Net Income to Common | 218.79 | 180.92 | 151.88 | 130.15 | 142.96 |
Net Income Growth | 14.00% | 22.66% | 18.79% | -7.87% | 17.80% |
Shares Outstanding (Basic) | 174 | 165 | 166 | 166 | 166 |
Shares Outstanding (Diluted) | 174 | 171 | 171 | 169 | 167 |
Shares Change (YoY) | 1.74% | -0.11% | 1.10% | 1.32% | 0.48% |
EPS (Basic) | 1.26 | 1.10 | 0.92 | 0.78 | 0.86 |
EPS (Diluted) | 1.26 | 1.10 | 0.92 | 0.78 | 0.86 |
EPS Growth | 14.57% | 20.10% | 17.49% | -9.38% | 17.81% |
Free Cash Flow | - | 99.8 | 9.31 | -62.75 | -205.07 |
Free Cash Flow Per Share | - | 0.58 | 0.05 | -0.37 | -1.23 |
Dividend Per Share | - | - | 0.270 | 0.240 | 0.260 |
Dividend Growth | - | - | 12.50% | -7.69% | -8.77% |
Gross Margin | 59.77% | 63.11% | 58.19% | 56.75% | 59.34% |
Operating Margin | 25.46% | 24.89% | 21.52% | 22.08% | 31.13% |
Profit Margin | 20.53% | 21.24% | 20.18% | 22.21% | 30.77% |
Free Cash Flow Margin | - | 11.71% | 1.24% | -10.71% | -44.13% |
EBITDA | 345.98 | 286.75 | 204.78 | 159.99 | 168.81 |
EBITDA Margin | 32.47% | 33.66% | 27.20% | 27.31% | 36.33% |
D&A For EBITDA | 74.73 | 74.73 | 42.79 | 30.65 | 24.17 |
EBIT | 271.24 | 212.02 | 161.99 | 129.34 | 144.64 |
EBIT Margin | 25.46% | 24.89% | 21.52% | 22.08% | 31.13% |
Effective Tax Rate | 9.93% | 10.94% | 12.50% | 7.36% | 9.79% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.